U.S., April 4 -- ClinicalTrials.gov registry received information related to the study (NCT06908252) titled 'MAPS PrEP Van Study' on March 20.
Brief Summary: For this study we aim to see if giving people an oral HIV prevention medication on a medical van, is a good option of care for individuals who inject drugs and/or are sexually active and therefore at a higher risk of contracting HIV.
Study Start Date: March 25
Study Type: INTERVENTIONAL
Condition:
HIV Infection
Intervention:
DRUG: Pre-Exposure Prophylaxis (PrEP)
Oral Pre-Exposure Prophylaxis (PrEP) pills
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Duke University
Disclaimer: Curated by HT Syndication....